AI assistant
Sending…
Barinthus Biotherapeutics plc. — Director's Dealing 2021
Apr 30, 2021
34488_dirs_2021-04-29_bb8a8651-9110-481e-92af-927c387b057f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vaccitech plc (VACC)
CIK: 0001828185
Period of Report: 2021-04-29
Reporting Person: DAWES KAREN A (Director)
More from Barinthus Biotherapeutics plc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Board/Management Information
2026
Apr 22
M&A Activity
2026
Feb 23
Delisting Announcement
2026
Jan 6
Regulatory Filings
2025
Dec 10
Interim / Quarterly Report
2025
Nov 7
Earnings Release
2025
Nov 7
M&A Activity
2025
Sep 30